Statements (42)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
inhibits viral DNA synthesis
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:approves |
gptkb:1995
gptkb:FDA |
| gptkbp:brand |
Valtrex
Valtrex 1000 mg Valtrex 500 mg |
| gptkbp:contraindication |
dehydration
renal impairment hypersensitivity to acyclovir |
| gptkbp:developed_by |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:dosage_form |
1000 mg tablet
500 mg tablet |
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
valacyclovir
|
| gptkbp:indication |
treatment of cold sores
prevention of cytomegalovirus infection suppressive therapy for recurrent genital herpes treatment of shingles |
| gptkbp:ingredients |
C13 H20 N4 O4
|
| gptkbp:interacts_with |
gptkb:mycophenolate_mofetil
gptkb:zidovudine probenecid |
| gptkbp:is_atype_of |
J05 A B08
|
| gptkbp:is_used_for |
treatment of herpes simplex virus
treatment of cytomegalovirus treatment of herpes zoster |
| gptkbp:lifespan |
2.5 to 3.3 hours
|
| gptkbp:manager |
oral
|
| gptkbp:metabolism |
gptkb:acyclovir
|
| gptkbp:monitors |
0 A2 D1 F1 B2 D
|
| gptkbp:side_effect |
dizziness
headache nausea diarrhea |
| gptkbp:type_of |
124832-265
|
| gptkbp:bfsParent |
gptkb:HSV-1
gptkb:HSV-2 gptkb:Simplexvirus gptkb:herpes |
| gptkbp:bfsLayer |
5
|